CEO: | Adrian Kinkaid |
Chairman: | Simon Gordon Douglas |
Chief Scientific Officer: | Richard John Buick |
Non-Executive Dir: | Colin Walsh, Matthew Baker |
Address: | Springbank Industrial Estate, 1 Springbank Rd, Dunmurry, Belfast, United Kingdom, BT17 0QL |
Website: | https://www.fusionantibodies.com/ |
Sector: | Health Care(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BDQZGK16 |
Currency | UK Pounds |
Share Price | 3.75p |
Change Today | -0.050p |
% Change | -1.32 % |
52 Week High | 44.00 |
52 Week Low | 3.20 |
Volume | 187,413 |
Shares Issued | 95.37m |
Market Cap | £3.58m |
RiskGrade | 464 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:27 | 28 @ 3.72p |
16:18 | 26 @ 3.72p |
16:06 | 107 @ 3.72p |
14:36 | 155 @ 3.71p |
12:57 | 26 @ 3.75p |
Chair | Simon Gordon Douglas |
CEO | Adrian Kinkaid |
You are here: research